Transaction · 0000950170-25-029434

Xie Jian

Xie Jian, PRES, reported a transaction classified as withholding at Fulgent Genetics, Inc. involving 4551.000000 shares for an estimated $73908.24. Reported holdings after the transaction were 380338.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FPRES
FLGTFulgent Genetics, Inc.
Filing timeFeb 28
Trade dateFeb 26, 2024
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

FLGT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
FLGT since 2025-02-28Filed 553 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0000950170-25-029434
Common Stock
Transaction date
Feb 26, 2024
Filed Feb 28, 2025, 02:04 AM · 368d delay
Shares
4.55k sh
$1.62k per share
Estimated value
-$7.39M
Computed from shares × price
Holdings after
380k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 368 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.

  2. F2

    Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.

  3. F3

    Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.

  4. F4

    The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting…

  5. F5

    The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting…

  6. F6

    The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting…

  7. F7

    Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares v…

  8. F8

    The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February…

  9. F9

    Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with…

Original filing · 0000950170-25-029434
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

FLGT